Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Bupivacaine × Thoracic × Clear all

Phase

Status

Completed 4 Unknown 2 Terminated 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1

Conditions

Lung Neoplasms 1 Disease 1 Agnosia 1

Interventions

Carboplatin 53 Drug Therapy 35 Cisplatin 33 Pemetrexed 32 osimertinib 21 Etoposide 18 pembrolizumab 17 anlotinib 17 Paclitaxel 16 tislelizumab 15 Surgical Procedures, Operative 15 Radiotherapy 13 aflutinib 12 Docetaxel 11 Bevacizumab 11 130-nm albumin-bound paclitaxel 11 toripalimab 10 sintilimab 10 durvalumab 10 Specimen Handling 10 cemiplimab 9 atezolizumab 9 Magnetic Resonance Spectroscopy 9 Injections 9 Immunotherapy 8 lorlatinib 7 Platinum Compounds 7 Platinum 7 PM 01183 7 ensartinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07254650 2025-11-28

CALMS-1

University of Texas Southwestern Medical Center

Phase NA Not yet recruiting

Agnosia, Disease, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡